Pathology, research and practice最新文献

筛选
英文 中文
Corrigendum to "Jiawei Jingxie Yin attenuates psoriasis recurrence and is associated with reduced NF-κB activation and memory γδ T cells in a mouse model" [Pathol. - Res. Pract. 284 (2026) 156483]. “加味经泻饮减轻银屑病复发,并与小鼠模型中NF-κB活化和记忆γδ T细胞减少有关”的更正[病理学杂志]。-惯例284(2026)156483]。
IF 3.7 4区 医学
Pathology, research and practice Pub Date : 2026-11-10 DOI: 10.1016/j.prp.2026.156727
Yu Lu, Xiaomei Zhou, Dengke Yang, Jie Wu
{"title":"Corrigendum to \"Jiawei Jingxie Yin attenuates psoriasis recurrence and is associated with reduced NF-κB activation and memory γδ T cells in a mouse model\" [Pathol. - Res. Pract. 284 (2026) 156483].","authors":"Yu Lu, Xiaomei Zhou, Dengke Yang, Jie Wu","doi":"10.1016/j.prp.2026.156727","DOIUrl":"https://doi.org/10.1016/j.prp.2026.156727","url":null,"abstract":"","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":" ","pages":"156727"},"PeriodicalIF":3.7,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abnormal mechanical loading disrupts mitochondrial homeostasis and is associated with ferroptosis in temporomandibular joint osteoarthritis. 异常机械负荷破坏线粒体稳态并与颞下颌关节骨性关节炎中的铁下垂有关。
IF 3.7 4区 医学
Pathology, research and practice Pub Date : 2026-11-07 DOI: 10.1016/j.prp.2026.156724
Xiaojie Diao, Wei He, Zhiqiang Song, Zhongcheng Gong
{"title":"Abnormal mechanical loading disrupts mitochondrial homeostasis and is associated with ferroptosis in temporomandibular joint osteoarthritis.","authors":"Xiaojie Diao, Wei He, Zhiqiang Song, Zhongcheng Gong","doi":"10.1016/j.prp.2026.156724","DOIUrl":"https://doi.org/10.1016/j.prp.2026.156724","url":null,"abstract":"<p><p>Abnormal mechanical loading is an important contributor to temporomandibular joint osteoarthritis (TMJOA), but how mechanical stress disrupts mitochondrial homeostasis and relates to ferroptosis remains unclear. This study demonstrates that mechanical loading induces mitochondrial dysfunction in condylar chondrocytes, characterized by a significant reduction in mitochondrial membrane potential without an obvious change in mitochondrial abundance. Mechanical stress was accompanied by reduced TOM20, MFN1, and HSP60 expression and increased PINK1/Parkin protein levels, together with altered LC3A and P62 expression, indicating activation of mitochondrial quality-control responses. Meanwhile, mechanical loading significantly increased intracellular Fe²⁺ and reactive oxygen species and was associated with increased MDA and ACSL4 and decreased GSH and GPX4. Ferrostatin-1 and deferoxamine partially attenuated these ferroptosis-associated alterations and improved cell viability. Consistently, mitochondrial abnormalities, altered mitophagy-related responses, and progressive ferroptosis-associated changes were observed in the unilateral anterior crossbite model, with early Fe²⁺ accumulation followed by more prominent changes in GPX4, ACSL4, GSH, and MDA during disease progression. Ferrostatin-1 partially alleviated cartilage and subchondral bone abnormalities. Collectively, these findings reveal that persistent mechanical stress disrupts mitochondrial homeostasis and is accompanied by altered mitochondrial quality-control responses and progressive ferroptosis-associated injury during TMJOA progression, providing new insights into the mitochondrial-ferroptosis axis underlying mechanically induced joint degeneration.</p>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"289 ","pages":"156724"},"PeriodicalIF":3.7,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The hypoxia, lactate and lactylation axis in lung disease: A metabolic and epigenetic framework. 肺部疾病的缺氧、乳酸和乳酸化轴:代谢和表观遗传框架。
IF 3.7 4区 医学
Pathology, research and practice Pub Date : 2026-11-05 DOI: 10.1016/j.prp.2026.156741
Mingxing Wu, Wenhui Xu, Yimin Zhu
{"title":"The hypoxia, lactate and lactylation axis in lung disease: A metabolic and epigenetic framework.","authors":"Mingxing Wu, Wenhui Xu, Yimin Zhu","doi":"10.1016/j.prp.2026.156741","DOIUrl":"https://doi.org/10.1016/j.prp.2026.156741","url":null,"abstract":"<p><p>Hypoxia accompanies diverse pulmonary diseases and can promote glycolytic reprogramming and lactate accumulation. Lactate serves as a metabolic fuel and signalling molecule and can supply substrates for protein lysine lactylation. These activities are related but experimentally distinct. Here, we evaluate a hypoxia, lactate and lactylation framework across pulmonary hypertension, lung cancer, pulmonary fibrosis, acute lung injury, chronic obstructive pulmonary disease and asthma. We distinguish studies that manipulate oxygen availability and measure downstream metabolic and lactylation responses from those that demonstrate lactate signalling or lactylation without establishing hypoxia as the initiating event. We assess evidence for individual mechanisms according to human validation, biochemical resolution and the specificity of in vivo interventions. This comparison identifies substantial gaps between an observed metabolic sequence and proof that a particular lactylation event mediates disease. We also examine how protein lactylation intersects with RNA-modifying enzymes and DNA-repair machinery, while recognizing that direct nucleic-acid lactylation remains unvalidated. Potential interventions range from lactate production and transport to lactylation regulators, but current agents frequently alter metabolism or other protein acylations. The framework therefore provides a basis for testing how oxygen stress influences pulmonary pathology rather than evidence for a uniformly established causal pathway or a clinically validated therapeutic class.</p>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"289 ","pages":"156741"},"PeriodicalIF":3.7,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149409409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NDRG1 mediates β-catenin nuclear translocation to activate Wnt/β-catenin signaling and regulate metabolic reprogramming and vasculogenic mimicry in NSCLC. NDRG1介导β-catenin核易位,激活Wnt/β-catenin信号通路,调节NSCLC代谢重编程和血管生成模拟。
IF 3.7 4区 医学
Pathology, research and practice Pub Date : 2026-11-03 DOI: 10.1016/j.prp.2026.156739
Linnan Yu, Hongying Zhai, Wendong Luo, Yongle Li, Shuang Gao, Yue Yang, Zhaoxia Dai
{"title":"NDRG1 mediates β-catenin nuclear translocation to activate Wnt/β-catenin signaling and regulate metabolic reprogramming and vasculogenic mimicry in NSCLC.","authors":"Linnan Yu, Hongying Zhai, Wendong Luo, Yongle Li, Shuang Gao, Yue Yang, Zhaoxia Dai","doi":"10.1016/j.prp.2026.156739","DOIUrl":"https://doi.org/10.1016/j.prp.2026.156739","url":null,"abstract":"<p><strong>Background: </strong>Non-small cell lung cancer (NSCLC) is the main subtype of lung cancers and is characterized by metabolic reprogramming and vasculogenic mimicry (VM), both of which contribute to tumor aggressiveness. Although N-myc downstream-regulated gene 1 (NDRG1) was implicated in NSCLC progression, its involvement in VM remains to be investigated. The aim of this study was to reveal the role of NDRG1 in VM within NSCLC.</p><p><strong>Methods: </strong>NDRG1 expression and prognostic relevance were analyzed using public databases and NSCLC tissue samples. NSCLC cell lines were used for NDRG1 knockdown or overexpression experiments. Cell proliferative capacity was assessed using the CCK-8 assay, whereas cell motility and invasiveness were determined by Transwell-based assays Metabolic changes were assessed by detecting lactate, triglyceride, cholesterol levels, and extracellular acidification rate (ECAR). VM was evaluated by CD34/PAS staining and VM-related protein expression. Wnt/β-catenin signaling was examined by Western blot, immunofluorescence, and a β-catenin inhibitor treatment.</p><p><strong>Results: </strong>NDRG1 expression was markedly elevated in NSCLC and was related to unfavorable prognosis and increased vasculogenic mimicry (VM). NDRG1 silencing suppressed glycolysis, lipid accumulation, cell proliferation, EMT, and angiogenic marker expression. Mechanistically, NDRG1 enhanced β-catenin nuclear translocation and activated Wnt/β-catenin signaling. Inhibition of β-catenin attenuated NDRG1-induced metabolic reprogramming and VM.</p><p><strong>Conclusion: </strong>NDRG1 facilitates NSCLC progression by activating Wnt/β-catenin signaling, thereby inducing metabolic reprogramming and VM. These findings suggest that the NDRG1/β-catenin axis may warrant further investigation as a potential therapeutic target in NSCLC, although its therapeutic relevance requires in vivo validation.</p>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"289 ","pages":"156739"},"PeriodicalIF":3.7,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CircRNA hsa_circ_0001946 promotes hypertrophic scar pathogenesis via the miR-514a-3p/COL5A2 axis. CircRNA hsa_circ_0001946通过miR-514a-3p/COL5A2轴促进增生性瘢痕发病。
IF 3.7 4区 医学
Pathology, research and practice Pub Date : 2026-10-01 Epub Date: 2026-08-03 DOI: 10.1016/j.prp.2026.156641
Yi Shi, Yajuan Song, Tong Wang, Yan Jiao, Yufei Zhang, Shu'ao Xiao, Baoqiang Song, Zhou Yu
{"title":"CircRNA hsa_circ_0001946 promotes hypertrophic scar pathogenesis via the miR-514a-3p/COL5A2 axis.","authors":"Yi Shi, Yajuan Song, Tong Wang, Yan Jiao, Yufei Zhang, Shu'ao Xiao, Baoqiang Song, Zhou Yu","doi":"10.1016/j.prp.2026.156641","DOIUrl":"10.1016/j.prp.2026.156641","url":null,"abstract":"<p><p>Hypertrophic scars (HSs) represent a fibroproliferative disorder characterized by excessive extracellular matrix deposition. However, the underlying regulatory mechanisms involving circular RNAs (circRNAs) have not yet been fully elucidated. This study aimed to delineate the circRNA expression landscape in HS and reveal the functional roles of a specific candidate circRNA through the competing endogenous RNA (ceRNA) network. Eighty-one differentially expressed circRNAs (DEcircRNAs) were identified in five paired HS and normal skin samples by high-throughput sequencing. Functional enrichment analysis of host genes highlighted pathways involving cell proliferation and ECM-receptor interactions. CircRNA-miRNA-mRNA network analysis revealed hsa_circ_0001946 as a significantly upregulated candidate circRNA. Subsequent RT-qPCR validated its elevation in human HS tissues and hypertrophic scar fibroblasts (HSFs). Subcellular fractionation and RNase R assays confirmed its cytoplasmic localization and circular stability. Functionally, knockdown of hsa_circ_0001946 significantly inhibited HSF proliferation, migration, and collagen gel contraction. Mechanistically, dual-luciferase reporter assays demonstrated that hsa_circ_0001946 acts as a sponge for miR-514a-3p; notably, silencing hsa_circ_0001946 attenuated the pro-fibrotic effects induced by miR-514a-3p inhibition. Furthermore, miR-514a-3p was shown to directly target and suppress COL5A2. Collectively, these findings establish that hsa_circ_0001946 promotes HS development by sequestering miR-514a-3p to derepress COL5A2 expression. This study identifies the hsa_circ_0001946/miR-514a-3p/COL5A2 axis as a novel pathogenic mechanism contributing to HS formation, suggesting hsa_circ_0001946 as a promising intervention target for mitigating pathological scarring.</p>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"286 ","pages":"156641"},"PeriodicalIF":3.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148685371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
B4GALNT4 promotes lung cancer progression by suppressing ferroptosis through glycosylation of SLC7A11 B4GALNT4通过SLC7A11的糖基化抑制铁下垂,从而促进肺癌进展
IF 3.2 4区 医学
Pathology, research and practice Pub Date : 2026-05-19 DOI: 10.1016/j.prp.2026.156548
Song Wu , Rongrong Shen , Shaofei Cheng , Zhengyang Fan , Hongyang Sang , Qianping Li
{"title":"B4GALNT4 promotes lung cancer progression by suppressing ferroptosis through glycosylation of SLC7A11","authors":"Song Wu ,&nbsp;Rongrong Shen ,&nbsp;Shaofei Cheng ,&nbsp;Zhengyang Fan ,&nbsp;Hongyang Sang ,&nbsp;Qianping Li","doi":"10.1016/j.prp.2026.156548","DOIUrl":"10.1016/j.prp.2026.156548","url":null,"abstract":"<div><div>β-1,4-N-acetylgalactosaminyltransferase 4 (B4GALNT4) catalyzes LacdiNAc glycan synthesis and is implicated in multiple cancers; however, its role in lung cancer remains unclear. This study aimed to investigate the clinical relevance, biological impact, and regulatory pathways of B4GALNT4 in lung cancer. B4GALNT4 expression across 33 cancers was analyzed using Gene Expression Profiling Interactive Analysis, and its level, prognostic relevance, and pathways enrichment in lung cancer were further assessed. Its effects on cell viability, cell cycle, and ferroptosis were evaluated with gain- and loss-of-function assays. Co-immunoprecipitation, protein stability assays, immunofluorescence, and Western and lectin blotting were performed to identify whether B4GALNT4 regulates solute carrier family 7 member 11 (SLC7A11) glycosylation. Rescue experiments were conducted to verify whether B4GALNT4 affected the malignant proliferation phenotype via the SLC7A11-mediated ferroptosis pathway. B4GALNT4 is upregulated, and its upregulation is associated with a worse prognosis in lung cancer. Gene Set Enrichment Analysis demonstrated enrichment of proliferation and cell cycle pathways, alongside ferroptosis suppression in B4GALNT4 high-expression samples. Functional experiments revealed that B4GALNT4 knockdown significantly inhibited lung cancer cell viability by 25.6% and induced a 1.92-, 2.03-, 1.76-, and 4.29-fold increase in the cell proportion in G1 phase, intracellular Fe²⁺, malondialdehyde levels, and lipid reactive oxygen species production (<em>P</em> &lt; 0.001), respectively, which were reversed by Fer-1 <em>in vitro</em> (<em>P</em> &lt; 0.001) and <em>in vivo</em> (<em>P</em> &lt; 0.05). Conversely, B4GALNT4 overexpression improved the resistance of cells to ferroptosis (<em>P</em> &lt; 0.001). Mechanistically, we discovered that B4GALNT4 interacted with SLC7A11 and glycosylated it at residue N314. This N-glycosylation stabilized SLC7A11 and promoted membrane localization by blocking its degradation, which promoted cell viability and cell cycle progression and inhibited ferroptosis. Our findings establish B4GALNT4 as a critical regulator of lung cancer through SLC7A11 glycosylation, indicating that B4GALNT4 and SLC7A11 serve as potential therapeutic targets for lung cancer.</div></div>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"285 ","pages":"Article 156548"},"PeriodicalIF":3.2,"publicationDate":"2026-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148000389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Granulocytic myeloid derived suppressor cells derived extracellular vesicles ameliorate DSS-induced colitis via modulation of Th17/Treg balance 粒细胞髓系来源的抑制细胞来源的细胞外囊泡通过调节Th17/Treg平衡改善dss诱导的结肠炎
IF 3.2 4区 医学
Pathology, research and practice Pub Date : 2026-05-01 Epub Date: 2026-02-12 DOI: 10.1016/j.prp.2026.156405
Juan Liu , Chinenye Jane Ugwah-Oguejiofor , Ling Zhu
{"title":"Granulocytic myeloid derived suppressor cells derived extracellular vesicles ameliorate DSS-induced colitis via modulation of Th17/Treg balance","authors":"Juan Liu ,&nbsp;Chinenye Jane Ugwah-Oguejiofor ,&nbsp;Ling Zhu","doi":"10.1016/j.prp.2026.156405","DOIUrl":"10.1016/j.prp.2026.156405","url":null,"abstract":"<div><div>Colitis is closely associated with immune system dysregulation in the gastrointestinal tract. The present study aimed to evaluate the impact of Granulocytic Myeloid-Derived Suppressor Cells (G-MDSCs)-derived extracellular vesicles (EVs) on disease activity and the immunologic profile in a murine model of colitis. G-MDSCs-EVs were administered to colitis-bearing mice and were evaluated for changes in body weight, disease activity index, colon histopathology, frequencies of Th17 and Tregs, and cytokine release from lymphocytes. The impact of G-MDSCs-EVs was also evaluated on the expression of immune-response-related genes and the intestinal microbiome. G-MDSCs-EVs prevented body weight loss and controlled the disease activity index on day 10. This treatment improved the Treg population along with a decrease in the release of IL-6, IL-17A, and IFN-γ from lymphocytes. Treatment with G-MDSCs-EVs modulated immune-response-related gene expression and influenced the gut microbiota and colon histopathology. G-MDSCs-EVs demonstrated a preliminary potential in expanding the Treg population and upregulating immunoregulatory cytokines, which contributed to improvements in disease activity index and histopathology of the affected tissue.</div></div>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"281 ","pages":"Article 156405"},"PeriodicalIF":3.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146196842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulation of AKT/GSK-3β signaling by ambrisentan alleviates chronic kidney disease ambrisentan调节AKT/GSK-3β信号通路可缓解慢性肾脏疾病
IF 3.2 4区 医学
Pathology, research and practice Pub Date : 2026-05-01 Epub Date: 2026-02-12 DOI: 10.1016/j.prp.2026.156402
Rohan Bhadange, Anil Bhanudas Gaikwad
{"title":"Modulation of AKT/GSK-3β signaling by ambrisentan alleviates chronic kidney disease","authors":"Rohan Bhadange,&nbsp;Anil Bhanudas Gaikwad","doi":"10.1016/j.prp.2026.156402","DOIUrl":"10.1016/j.prp.2026.156402","url":null,"abstract":"<div><div>Chronic kidney disease (CKD) is a progressive disease leading to severe health complications. Repurposing of existing drugs offers an attractive avenue for advancing drug development in CKD. Ambrisentan (AMB), a selective ET-1<sub>A</sub> receptor antagonist used in pulmonary arterial hypertension, holds promise in CKD management. Hence, we aimed to investigate the potential of AMB in unilateral ureteral obstruction (UUO)-induced kidney fibrosis in Sprague-Dawley rats and in recombinant human-transforming growth factor-β1 (rh-TGF-β1)-induced fibrosis in NRK-52E cells. Animals were randomly assigned to the sham, UUO, and UUO + AMB (0.5 mg/kg, <em>p.o., o.d.</em>) groups for 21 days. Animals were sacrificed post-treatment, and plasma, urine, and kidney specimens were collected for biochemistry, histology, immunohistochemistry and qRT-PCR. Moreover, NRK-52E cells were exposed to AMB (100 µM) for 48 h and cell samples were collected for cell viability, morphology, immunocytochemistry, immunoblotting, and flow cytometry assays. AMB treatment significantly improves the left kidney weight, kidney mass ratio, kidney function parameters, and plasma protein levels of TGF-β1 and collagen I. Histopathology revealed that AMB treatment significantly preserved kidney histoarchitecture and interstitial fibrosis in UUO kidneys. Mechanistically, AMB suppressed phosphorylation of AKT and GSK-3β, downregulated α-SMA, vimentin and restored E-cadherin expression as shown by immunocytochemistry, immunohistochemistry and immunoblotting assay. Furthermore, AMB mitigated rh-TGF-β1-induced apoptosis, as assessed by flow cytometry, and modulated Bax, Bcl-2, and cleaved caspase-3 expression, as revealed by qRT-PCR and immunohistochemistry. Collectively, the findings indicate that the AMB modulates the AKT/GSK-3β axis, halting fibrotic progression in CKD, suggesting its clinical potential.</div></div>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"281 ","pages":"Article 156402"},"PeriodicalIF":3.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146196841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TFAP2A facilitates aerobic glycolysis and metastasis of pancreatic cancer via IGF2BP2-mediated LDHA m6A modification TFAP2A通过igf2bp2介导的LDHA m6A修饰促进胰腺癌的有氧糖酵解和转移。
IF 3.2 4区 医学
Pathology, research and practice Pub Date : 2026-04-01 Epub Date: 2026-01-31 DOI: 10.1016/j.prp.2026.156387
Zhiying Xu, Xingyang Zhong, Zhishi Yang, Zhuangzhi Cong, Lianwei Peng, Qifei Zou
{"title":"TFAP2A facilitates aerobic glycolysis and metastasis of pancreatic cancer via IGF2BP2-mediated LDHA m6A modification","authors":"Zhiying Xu,&nbsp;Xingyang Zhong,&nbsp;Zhishi Yang,&nbsp;Zhuangzhi Cong,&nbsp;Lianwei Peng,&nbsp;Qifei Zou","doi":"10.1016/j.prp.2026.156387","DOIUrl":"10.1016/j.prp.2026.156387","url":null,"abstract":"<div><div>The hallmark of aerobic glycolysis in cancer progression is well-established, yet its specific role in pancreatic cancer (PC) remains elusive. Here, we reported that TFAP2A is upregulated in PC tissues, and elevated TFAP2A expression correlates with poor prognosis in patients. Functionally, we found that TFAP2A boosted the viability, invasion, and migration of PC cells <em>in vitro</em>, whereas TFAP2A depletion restrained tumor growth <em>in vivo</em>. Moreover, TFAP2A knockdown hindered aerobic glycolysis of PC cells. Further investigation revealed that TFAP2A deletion decreased LDHA expression in PC cells. LDHA overexpression counteracted the impacts of TFAP2A deletion on cell viability, migration, invasion, and aerobic glycolysis. Mechanistically, TFAP2A was directly bound to the promoter of IGF2BP2, upregulating its expression. Additionally, IGF2BP2 was found to bind to the m<sup>6</sup>A site in LDHA mRNA, thereby enhancing its stability. Overall, TFAP2A facilitated aerobic glycolysis and PC progression via IGF2BP2-mediated stabilization of LDHA mRNA, providing novel insights for PC therapy.</div></div>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"280 ","pages":"Article 156387"},"PeriodicalIF":3.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146132634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of PCOS management: Disease modification through regenerative, metabolic, and digital therapeutics 多囊卵巢综合征管理的未来:通过再生、代谢和数字治疗来改变疾病。
IF 3.2 4区 医学
Pathology, research and practice Pub Date : 2026-04-01 Epub Date: 2026-02-05 DOI: 10.1016/j.prp.2026.156397
Ruhi Arisha , Shivam Sengupta , Hitesh Kumar Dewangan , Abdulaziz S. Saeedan , Mohd Nazam Ansari , Summya Rashid
{"title":"The future of PCOS management: Disease modification through regenerative, metabolic, and digital therapeutics","authors":"Ruhi Arisha ,&nbsp;Shivam Sengupta ,&nbsp;Hitesh Kumar Dewangan ,&nbsp;Abdulaziz S. Saeedan ,&nbsp;Mohd Nazam Ansari ,&nbsp;Summya Rashid","doi":"10.1016/j.prp.2026.156397","DOIUrl":"10.1016/j.prp.2026.156397","url":null,"abstract":"<div><div>Polycystic ovary syndrome (PCOS) represents the leading endocrine problem affecting women of reproductive age, leading to serious complications related to reproduction, metabolism, and psychosocial aspects. Nonetheless, due to the heterogeneous nature and complex pathophysiology associated with PCOS, this condition remains uncaptured or undertreated as it often gets diagnosed at an advanced age due to its prevalence. The pathophysiology associated with PCOS involves the combination of genetic factors, resistance, neuroendocrine imbalance, as well as environmental factors that contribute towards hyperandrogenism, ovulation defects, and metabolic disorders as well. Hence, a comprehensive literature survey was conducted using PubMed, Scopus, Web of Science, and Google Scholar, prioritizing international clinical guidelines, meta-analyses, randomized controlled trials, systematic reviews, and high-quality preclinical studies that covered publications from 2015 to 2025, with the search terms being keywords specific to the disease. At present, the treatments such as lifestyle correction, combined oral pills, and anti-insulin therapies along with anti-androgen drugs only have symptomatic roles with no impact on the underlying mechanism associated with PCOS. However, new therapeutic modalities have been proposed from the past few years that is addressed by this narrative review, including mesenchymal stem cell-based therapies, microbiome therapies, as well as second-generation pharmacotherapies such as GLP-1 agonists and SGLT2 inhibitors. This is being complemented by equal developments in artificial intelligence and the learning process. However, there is work that needs to be done in relation to harmonizing the criteria for diagnosis and the long-term safety and accessibility of effective treatments. Moving forward, the focus should be placed on phenotype-based, precision, and multidisciplinary treatments of PCOS, along with emphasizing the necessity of sturdy clinical validation before worldwide adoption.</div></div>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"280 ","pages":"Article 156397"},"PeriodicalIF":3.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146157664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书